SULT4A1: A Protein Involved in Nervous System Development and Maintenance

Target Name: SULT4A1

NCBI ID: G25830

SULT4A1

SULT4A1: A Protein Involved in Nervous System Development and Maintenance

SULT4A1, also known as nervous system sulfotransferase, is a protein that is expressed in a wide range of tissues throughout the body. It is a member of the SULT gene family, which encodes a family of cytoskeletal proteins that are involved in the regulation of cell structure and function. SULT4A1 is primarily expressed in the nervous system, where it plays a role in the development and maintenance of the nervous system structure and function.

SULT4A1 is involved in a variety of physiological processes that are critical to the function of the nervous system. One of its main functions is to regulate the structure and function of the nervous system cell, which is essential for the proper functioning of the entire system. SULT4A1 helps to maintain the cytoskeleton in a flexible and stable state, which allows the cells to move and function properly. It also helps to regulate the production of new neurons, which is critical for the development and maintenance of the nervous system.

In addition to its role in the nervous system, SULT4A1 is also involved in other physiological processes that are important for the overall health and function of the body. For example, it has been shown to play a role in the regulation of inflammation, which is important for the immune system's ability to protect the body against infection and disease. It also has been shown to be involved in the regulation of cell growth and the development of cancer.

SULT4A1 is a potential drug target for a variety of neurological and psychiatric disorders. For example, it has been shown to be involved in the development and progression of Alzheimer's disease, which is the most common form of dementia. Studies have also shown that SULT4A1 is involved in the development and progression of other neurological disorders, such as Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis.

In addition to its potential clinical applications, SULT4A1 is also an important biomarker for a variety of neurological disorders. For example, it has been shown to be an effective biomarker for the diagnosis of Alzheimer's disease, with higher levels of SULT4A1 in the brain being associated with an increased risk of the disease. It is also a potential biomarker for other neurological disorders, such as Parkinson's disease and multiple sclerosis.

SULT4A1 is a complex protein that is involved in a wide range of physiological processes that are critical to the function of the nervous system. Its role in the regulation of cell structure and function, as well as its involvement in the development and maintenance of the nervous system, make it an important protein that should be further studied. Additionally, its potential as a drug target and biomarker make it a promising target for future research.

Protein Name: Sulfotransferase Family 4A Member 1

Functions: Atypical sulfotransferase family member with very low affinity for 3'-phospho-5'-adenylyl sulfate (PAPS) and very low catalytic activity towards L-triiodothyronine, thyroxine, estrone, p-nitrophenol, 2-naphthylamine, and 2-beta-naphthol. May have a role in the metabolism of drugs and neurotransmitters in the CNS

The "SULT4A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SULT4A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets